Steven Seung is an Oncology physician affiliated with Providence Portland Medical Center. OpenAlex indexes 38 publications with 1,068 citations (h-index 15); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4805 NE Glisan St
Garden Level
Portland, OR 972132933
Telephone
503-215-6029Provider last certified this registry record 5 Dec 2023.
Clinical trials
- Stereotactic Body Radiation and Monoclonal Antibody to OX40 (MEDI6469) in Breast Cancer Patients With Metastatic Lesions
Sponsor: Providence Health & Services
- Comparison of High-dose IL-2 and High-dose IL-2 With Radiation Therapy in Patients With Metastatic Melanoma.
Sponsor: Providence Health & Services
- Selective Dose Escalation for Esophageal Cancer
Sponsor: The Oregon Clinic
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
13 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Elekta, Inc.Program year202511 payments
- Sumitomo Pharma America, Inc.Program year20253 payments
- Telix PharmaceuticalsProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- MRI-Linac radiation therapy outcomes in patients with prostate, breast and other advanced malignancies.
Journal of Clinical Oncology
2024 - Patterns of utilization and clinical adoption of 0.35 Tesla MR-guided radiation therapy in the United States – Understanding the transition to adaptive, ultra-hypofractionated treatments
Clinical and Translational Radiation Oncology
2022 - Patterns of Utilization and Clinical Adoption of 0.35 MR-Guided Radiation Therapy in the United States — Understanding the Transition to Adaptive, Ultra-Hypofractionated Treatments
International Journal of Radiation Oncology*Biology*Physics
2021
Similar KOLs
Other experts from the same institution or the same specialty.
John Heffner, MD
Providence Portland Medical Center
Alison Conlin, MD
Providence Portland Medical Center
David Page, MD
Providence Portland Medical Center
Rom Leidner, MD
Providence Portland Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”